BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 10706696)

  • 1. Induction of diabetes in nonobese diabetic mice by Th2 T cell clones from a TCR transgenic mouse.
    Poulin M; Haskins K
    J Immunol; 2000 Mar; 164(6):3072-8. PubMed ID: 10706696
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A glutamic acid decarboxylase 65-specific Th2 cell clone immunoregulates autoimmune diabetes in nonobese diabetic mice.
    Tisch R; Wang B; Atkinson MA; Serreze DV; Friedline R
    J Immunol; 2001 Jun; 166(11):6925-36. PubMed ID: 11359854
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Regulation of diabetes development by regulatory T cells in pancreatic islet antigen-specific TCR transgenic nonobese diabetic mice.
    Kanagawa O; Militech A; Vaupel BA
    J Immunol; 2002 Jun; 168(12):6159-64. PubMed ID: 12055228
    [TBL] [Abstract][Full Text] [Related]  

  • 4. T helper cell subsets in insulin-dependent diabetes.
    Katz JD; Benoist C; Mathis D
    Science; 1995 May; 268(5214):1185-8. PubMed ID: 7761837
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparison of a T cell clone and of T cells from a TCR transgenic mouse: TCR transgenic T cells specific for self-antigen are atypical.
    Dobbs C; Haskins K
    J Immunol; 2001 Feb; 166(4):2495-504. PubMed ID: 11160310
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Thymic and postthymic regulation of diabetogenic CD8 T cell development in TCR transgenic nonobese diabetic (NOD) mice.
    Kanagawa O; Shimizu J; Vaupel BA
    J Immunol; 2000 May; 164(10):5466-73. PubMed ID: 10799914
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pathogenicity of T helper 2 T-cell clones from T-cell receptor transgenic non-obese diabetic mice is determined by tumour necrosis factor-alpha.
    He J; Haskins K
    Immunology; 2008 Jan; 123(1):108-17. PubMed ID: 17983440
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Paralytic autoimmune myositis develops in nonobese diabetic mice made Th1 cytokine-deficient by expression of an IFN-gamma receptor beta-chain transgene.
    Serreze DV; Pierce MA; Post CM; Chapman HD; Savage H; Bronson RT; Rothman PB; Cox GA
    J Immunol; 2003 Mar; 170(5):2742-9. PubMed ID: 12594305
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The activity of immunoregulatory T cells mediating active tolerance is potentiated in nonobese diabetic mice by an IL-4-based retroviral gene therapy.
    Yamamoto AM; Chernajovsky Y; Lepault F; Podhajcer O; Feldmann M; Bach JF; Chatenoud L
    J Immunol; 2001 Apr; 166(8):4973-80. PubMed ID: 11290776
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pancreatic IL-4 expression results in islet-reactive Th2 cells that inhibit diabetogenic lymphocytes in the nonobese diabetic mouse.
    Gallichan WS; Balasa B; Davies JD; Sarvetnick N
    J Immunol; 1999 Aug; 163(3):1696-703. PubMed ID: 10415077
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Lipopolysaccharide-activated B cells down-regulate Th1 immunity and prevent autoimmune diabetes in nonobese diabetic mice.
    Tian J; Zekzer D; Hanssen L; Lu Y; Olcott A; Kaufman DL
    J Immunol; 2001 Jul; 167(2):1081-9. PubMed ID: 11441119
    [TBL] [Abstract][Full Text] [Related]  

  • 12. T helper 2 (Th2) T cells induce acute pancreatitis and diabetes in immune-compromised nonobese diabetic (NOD) mice.
    Pakala SV; Kurrer MO; Katz JD
    J Exp Med; 1997 Jul; 186(2):299-306. PubMed ID: 9221759
    [TBL] [Abstract][Full Text] [Related]  

  • 13. CD4 T cells selected by antigen under Th2 polarizing conditions favor an elongated TCR alpha chain complementarity-determining region 3.
    Boyton RJ; Zaccai N; Jones EY; Altmann DM
    J Immunol; 2002 Feb; 168(3):1018-27. PubMed ID: 11801634
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Transfer of diabetes in the NOD-scid mouse by CD4 T-cell clones. Differential requirement for CD8 T-cells.
    Peterson JD; Haskins K
    Diabetes; 1996 Mar; 45(3):328-36. PubMed ID: 8593938
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The Presence and Preferential Activation of Regulatory T Cells Diminish Adoptive Transfer of Autoimmune Diabetes by Polyclonal Nonobese Diabetic (NOD) T Cell Effectors into NSG versus NOD-scid Mice.
    Presa M; Chen YG; Grier AE; Leiter EH; Brehm MA; Greiner DL; Shultz LD; Serreze DV
    J Immunol; 2015 Oct; 195(7):3011-9. PubMed ID: 26283479
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Adoptive transfer of diabetes into immunodeficient NOD-scid/scid mice. Relative contributions of CD4+ and CD8+ T-cells from diabetic versus prediabetic NOD.NON-Thy-1a donors.
    Christianson SW; Shultz LD; Leiter EH
    Diabetes; 1993 Jan; 42(1):44-55. PubMed ID: 8093606
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Generation, maintenance, and adoptive transfer of diabetogenic T-cell lines/clones from the nonobese diabetic mouse.
    Milton MJ; Poulin M; Mathews C; Piganelli JD
    Methods Mol Med; 2004; 102():213-25. PubMed ID: 15286388
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cutting edge: interactions through the IL-10 receptor regulate autoimmune diabetes.
    Phillips JM; Parish NM; Drage M; Cooke A
    J Immunol; 2001 Dec; 167(11):6087-91. PubMed ID: 11714766
    [TBL] [Abstract][Full Text] [Related]  

  • 19. CD4+ beta islet cell-reactive T cell clones that suppress autoimmune diabetes in nonobese diabetic mice.
    Akhtar I; Gold JP; Pan LY; Ferrara JL; Yang XD; Kim JI; Tan KN
    J Exp Med; 1995 Jul; 182(1):87-97. PubMed ID: 7790825
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mature mainstream TCR alpha beta+CD4+ thymocytes expressing L-selectin mediate "active tolerance" in the nonobese diabetic mouse.
    Herbelin A; Gombert JM; Lepault F; Bach JF; Chatenoud L
    J Immunol; 1998 Sep; 161(5):2620-8. PubMed ID: 9725264
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.